Published in Vaccine on June 20, 2003
Langerhans cells cross-present antigen derived from skin. Proc Natl Acad Sci U S A (2006) 1.98
Layer-by-layer-assembled multilayer films for transcutaneous drug and vaccine delivery. ACS Nano (2009) 1.75
Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells. J Clin Invest (2004) 1.58
A role for CCR4 in development of mature circulating cutaneous T helper memory cell populations. J Exp Med (2005) 1.54
Cutting Edge: Chemokine receptor CCR4 is necessary for antigen-driven cutaneous accumulation of CD4 T cells under physiological conditions. J Immunol (2007) 1.39
Expansion of antigen-specific regulatory T cells with the topical vitamin d analog calcipotriol. J Immunol (2009) 1.26
Adjuvants for human vaccines. Curr Opin Immunol (2012) 1.25
Langerhans cells as targets for immunotherapy against skin cancer. Immunol Cell Biol (2010) 1.06
Effect of skin barrier disruption on immune responses to topically applied cross-reacting material, CRM(197), of diphtheria toxin. Infect Immun (2005) 0.91
Transcutaneous immunization with cytotoxic T-cell peptide epitopes provides effective antitumor immunity in mice. J Immunother (2005) 0.86
Cholera toxin activates nonconventional adjuvant pathways that induce protective CD8 T-cell responses after epicutaneous vaccination. Proc Natl Acad Sci U S A (2012) 0.85
Immunological activation following transcutaneous delivery of HR-gp100 protein. Vaccine (2007) 0.80
Vaccination of mice using the West Nile virus E-protein in a DNA prime-protein boost strategy stimulates cell-mediated immunity and protects mice against a lethal challenge. PLoS One (2014) 0.79
Topical CpG adjuvantation of a protein-based vaccine induces protective immunity to Listeria monocytogenes. Clin Vaccine Immunol (2014) 0.77
Psoriasis and pustular dermatitis triggered by TNF-{alpha} inhibitors in patients with rheumatologic conditions. Arch Dermatol (2007) 4.36
Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood. J Clin Invest (2003) 2.37
Signaling lymphocytic activation molecule-associated protein controls NKT cell functions. J Immunol (2005) 1.98
The Ca(v)1.4 calcium channel is a critical regulator of T cell receptor signaling and naive T cell homeostasis. Immunity (2011) 1.73
Telomere erosion in memory T cells induced by telomerase inhibition at the site of antigenic challenge in vivo. J Exp Med (2004) 1.71
Topical resiquimod promotes priming of CTL to parenteral antigens. Vaccine (2009) 1.50
Usefulness of Interferon-γ release assays in the diagnosis of erythema induratum. Arch Dermatol (2011) 1.40
Cutting edge: Increased IL-17-secreting T cells in children with new-onset type 1 diabetes. J Immunol (2010) 1.40
Molecular dissection of 2B4 signaling: implications for signal transduction by SLAM-related receptors. Mol Cell Biol (2004) 1.38
In situ beta cell death promotes priming of diabetogenic CD8 T lymphocytes. J Immunol (2002) 1.30
Identification of a beta-cell-specific HLA class I restricted epitope in type 1 diabetes. Diabetes (2003) 1.30
Expansion of antigen-specific regulatory T cells with the topical vitamin d analog calcipotriol. J Immunol (2009) 1.26
Rapid and fatal meningococcal disease due to a strain of Neisseria meningitidis containing the capsule null locus. Clin Infect Dis (2005) 1.25
New concepts in antimalarial use and mode of action in dermatology. Dermatol Ther (2007) 1.24
A deficiency in the in vivo clearance of apoptotic cells is a feature of the NOD mouse. J Autoimmun (2006) 1.22
Identification of Novel HLA-A*0201-restricted epitopes in recent-onset type 1 diabetic subjects and antibody-positive relatives. Diabetes (2006) 1.21
Phagocytosis of apoptotic cells by macrophages from NOD mice is reduced. Diabetes (2002) 1.20
Recognition of HLA class I-restricted beta-cell epitopes in type 1 diabetes. Diabetes (2006) 1.20
Decidual NK cells alter in vitro first trimester extravillous cytotrophoblast migration: a role for IFN-gamma. J Immunol (2006) 1.17
Detection and genotyping of varicella-zoster virus by TaqMan allelic discrimination real-time PCR. J Clin Microbiol (2004) 1.17
Better influenza vaccines for older people: what will it take? J Infect Dis (2008) 1.17
Nutrition in primary care: current practices, attitudes, and barriers. Can Fam Physician (2010) 1.15
Pathophysiology of cutaneous lupus erythematosus. Clin Rev Allergy Immunol (2007) 1.11
Prevention of murine autoimmune diabetes by CCL22-mediated Treg recruitment to the pancreatic islets. J Clin Invest (2011) 1.10
TLR9 blockade inhibits activation of diabetogenic CD8+ T cells and delays autoimmune diabetes. J Immunol (2010) 1.09
Regulation of autoimmune diabetes by complete Freund's adjuvant is mediated by NK cells. J Immunol (2004) 1.08
Molecular markers of early-stage mycosis fungoides. J Invest Dermatol (2012) 1.04
Tolerance induction by transcutaneous immunization through ultraviolet-irradiated skin is transferable through CD4+CD25+ T regulatory cells and is dependent on host-derived IL-10. J Immunol (2006) 1.00
Differences in body mass index among individuals with PsA, psoriasis, RA and the general population. Rheumatology (Oxford) (2011) 1.00
In vivo control of acute lymphoblastic leukemia by immunostimulatory CpG oligonucleotides. Blood (2006) 1.00
Innate immune control of EBV-infected B cells by invariant natural killer T cells. Blood (2013) 0.99
Murine CD160, Ig-like receptor on NK cells and NKT cells, recognizes classical and nonclassical MHC class I and regulates NK cell activation. J Immunol (2005) 0.98
Angiogenic factors as diagnostic tests for preeclampsia: a performance comparison between two commercial immunoassays. Am J Obstet Gynecol (2011) 0.98
Protein kinase D interaction with TLR5 is required for inflammatory signaling in response to bacterial flagellin. J Immunol (2007) 0.98
Apolipoprotein-mediated lipid antigen presentation in B cells provides a pathway for innate help by NKT cells. Blood (2009) 0.96
Active vitamin D (1,25-dihydroxyvitamin D3) increases host susceptibility to Citrobacter rodentium by suppressing mucosal Th17 responses. Am J Physiol Gastrointest Liver Physiol (2012) 0.95
An association between cytomegalovirus infection and pre-eclampsia: a case-control study and data synthesis. Acta Obstet Gynecol Scand (2010) 0.94
Association of the X-linked lymphoproliferative disease gene product SAP/SH2D1A with 2B4, a natural killer cell-activating molecule, is dependent on phosphoinositide 3-kinase. J Biol Chem (2002) 0.94
Livedoid vasculopathy: an in-depth analysis using a modified Delphi approach. J Am Acad Dermatol (2013) 0.94
TLR5 is not required for flagellin-mediated exacerbation of DSS colitis. Inflamm Bowel Dis (2010) 0.93
Topical CpG enhances the response of murine malignant melanoma to dacarbazine. J Invest Dermatol (2008) 0.93
Reversible retiform purpura: a sign of cocaine use. CMAJ (2011) 0.92
Thymocyte selection-associated high mobility group box gene (TOX) is aberrantly over-expressed in mycosis fungoides and correlates with poor prognosis. Oncotarget (2014) 0.92
Can placental growth factor in maternal circulation identify fetuses with placental intrauterine growth restriction? Am J Obstet Gynecol (2011) 0.92
The central repeat domain 1 of Kaposi's sarcoma-associated herpesvirus (KSHV) latency associated-nuclear antigen 1 (LANA1) prevents cis MHC class I peptide presentation. Virology (2011) 0.92
The X-linked inhibitor of apoptosis protein enhances survival of murine islet allografts. Diabetes (2005) 0.90
RasGRP1 regulates antigen-induced developmental programming by naive CD8 T cells. J Immunol (2009) 0.90
Role for glycogen synthase kinase-3 in NK cell cytotoxicity and X-linked lymphoproliferative disease. J Immunol (2005) 0.90
Synthetic methylated CpG ODNs are potent in vivo adjuvants when delivered in liposomal nanoparticles. Int Immunol (2009) 0.90
Epicutaneous application of CpG oligodeoxynucleotides with peptide or protein antigen promotes the generation of CTL. J Invest Dermatol (2004) 0.89
CD1d and CD1c expression in human B cells is regulated by activation and retinoic acid receptor signaling. J Immunol (2011) 0.87
Oxidative stress enhances IL-8 and inhibits CCL20 production from intestinal epithelial cells in response to bacterial flagellin. Am J Physiol Gastrointest Liver Physiol (2010) 0.86
Protein kinase D1 and D2 are involved in chemokine release induced by toll-like receptors 2, 4, and 5. Cell Immunol (2010) 0.86
The stress signal extracellular ATP modulates antiflagellin immune responses in intestinal epithelial cells. Inflamm Bowel Dis (2010) 0.85
Islet allograft rejection is independent of toll-like receptor signaling in mice. Transplantation (2009) 0.85
Psychiatric disorders in patients with immune-mediated inflammatory diseases: prevalence, association with disease activity, and overall patient well-being. J Rheumatol Suppl (2011) 0.85
Short-term stability of pathogen-specific nucleic acid targets in clinical samples. J Clin Microbiol (2012) 0.85
Treatment of atypical nevi with imiquimod 5% cream. Arch Dermatol (2007) 0.85
Chronic active Epstein-Barr virus infection associated with low expression of leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) on natural killer cells. J Clin Immunol (2003) 0.84
Evaluation of a diagnostic polymerase chain reaction assay for Neisseria meningitidis in North America and field experience during an outbreak. Arch Pathol Lab Med (2002) 0.84
Critical role for IFN-gamma in natural killer cell-mediated protection from diabetes. Eur J Immunol (2008) 0.84
Natural killer cells from children with type 1 diabetes have defects in NKG2D-dependent function and signaling. Diabetes (2011) 0.83
IFN-gamma-mediated extravillous trophoblast outgrowth inhibition in first trimester explant culture: a role for insulin-like growth factors. Mol Hum Reprod (2008) 0.83
Type 1 IFN-induced protein MxA and plasmacytoid dendritic cells in lesions of morphea. Exp Dermatol (2012) 0.83
Murine models of cutaneous involvement in lupus erythematosus. Autoimmun Rev (2009) 0.82
ε-MnO2 nanostructures directly grown on Ni foam: a cathode catalyst for rechargeable Li-O2 batteries. Nanoscale (2014) 0.82
Topical TLR9 agonists induce more efficient cross-presentation of injected protein antigen than parenteral TLR9 agonists do. Eur J Immunol (2007) 0.82
T-cell epitopes in type 1 diabetes. Curr Diab Rep (2004) 0.81
Sulfur nanodots electrodeposited on ni foam as high-performance cathode for Li-S batteries. Nano Lett (2015) 0.81
NKT cells are required for complete Freund's adjuvant-mediated protection from autoimmune diabetes. J Immunol (2011) 0.81
Progression of spontaneous autoimmune diabetes is associated with a switch in the killing mechanism used by autoreactive CTL. Int Immunol (2004) 0.80
Hydrogenated uniform Pt clusters supported on porous CaMnO(3) as a bifunctional electrocatalyst for enhanced oxygen reduction and evolution. Adv Mater (2014) 0.79
Chlamydia pneumoniae infection in preeclampsia. Hypertens Pregnancy (2010) 0.79
Optimizing outcomes of hematopoietic stem cell transplantation for severe combined immunodeficiency. Clin Immunol (2009) 0.79
The X-linked lymphoproliferative syndrome gene product SAP regulates B cell function through the FcgammaRIIB receptor. Cell Signal (2008) 0.79
Toll-like receptor gene polymorphisms and preeclampsia risk: a case-control study and data synthesis. Hypertens Pregnancy (2010) 0.78
Antennapedia transduction sequence promotes anti tumour immunity to epicutaneously administered CTL epitopes. Vaccine (2004) 0.78
CCL22 Prevents Rejection of Mouse Islet Allografts and Induces Donor-Specific Tolerance. Cell Transplant (2015) 0.78
Inhibition of cathepsin S reduces allogeneic T cell priming but not graft-versus-host disease against minor histocompatibility antigens. Biol Blood Marrow Transplant (2011) 0.78
Skin immune responses to peptide and protein antigen are TLR4 independent. Cell Immunol (2003) 0.78
Fabry International Prognostic Index: a predictive severity score for Anderson-Fabry disease. J Med Genet (2012) 0.77
Topical CpG adjuvantation of a protein-based vaccine induces protective immunity to Listeria monocytogenes. Clin Vaccine Immunol (2014) 0.77
Decidual NK cell-derived conditioned medium (dNK-CM) mediates VEGF-C secretion in extravillous cytotrophoblasts. Am J Reprod Immunol (2011) 0.77
Atrophie blanche: is it associated with venous disease or livedoid vasculopathy? Adv Skin Wound Care (2014) 0.77
Tumor necrosis factor-a inhibition and palmoplantar pustulosis: Janus-faced therapy? J Rheumatol (2007) 0.77
Quality of life in patients with immune-mediated inflammatory diseases. J Rheumatol Suppl (2011) 0.77
Clinical and genetic registries in psoriatic disease. J Rheumatol (2008) 0.76
Xenogeneic beta 2-microglobulin substitution affects functional binding of MHC class I molecules by CD8+ T cells. J Immunol (2007) 0.76
T regulatory cell chemokine production mediates pathogenic T cell attraction and suppression. J Clin Invest (2016) 0.76
The p110α and p110β isoforms of class I phosphatidylinositol 3-kinase are involved in toll-like receptor 5 signaling in epithelial cells. Mediators Inflamm (2010) 0.75